| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
HealthEquity, Inc
$89.98
-14.53 (-13.92%)
Market Cap
7.50 B
EPS
2.76
P/E Ratio
37.84 $
Value Trade
66.52 M
0.14 %
Week
3.14 %
1 Month
15.36 %
3 Month
34.93 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
334.71 K
52 Week Range
72.76 - 107.62
% held by Insiders
2.62 %
% held by Institutions
108.47 %
Enterprise Value
8.18 B
Total Shares
83.60 M
Short %
5.06 %
Float Shares
82.08 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in HQY
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
HQY Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-10-16 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-10-16 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-10-16 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-HQY
Aug 27, 2026▼ -13.9%today
HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
HealthEquity reported strong financial results for the second quarter ended July 31, 2026, with a 10% increase in net income to $65.6 million and an 8% rise in revenue to $350.7 million. The company achieved a record Adjusted EBITDA margin of 48% and total HSA assets increased by 14%. Management has raised its fiscal 2027 guidance, reflecting confidence in ongoing growth.
Read more →-HQY
Aug 3, 2026HealthEquity Announces Second Quarter Earnings Release Date and Investor Conference Schedule
HealthEquity, Inc. has announced the release date for its second quarter fiscal 2027 earnings, set for August 27, 2026. Following the release, a conference call will be held to discuss the results. The company also plans to engage with investors at upcoming conferences, highlighting its position as a leader in health savings accounts.
Read more →-HQY
May 5, 2026HealthEquity Announces First Quarter Earnings Release Date and Investor Conference Schedule
HealthEquity, Inc. announced the release date for its first quarter fiscal 2027 earnings, set for May 28, 2026. Following the earnings release, a conference call will be held to discuss the results. The company also plans to engage with investors at various upcoming conferences, emphasizing its commitment to transparency and investor relations.
Read more →-HQY
Sep 19, 2023Conduent Incorporated 100 Campus Drive Florham Park, N.J. 07932 www.Conduent.com Conduent's BenefitWallet HSA Portfolio Moving to HealthEquity FLORHAM PARK, N.J., and Draper, UT
Conduent Incorporated has entered into a definitive agreement with HealthEquity to transfer BenefitWallet's Health Savings Account (HSA) portfolio for approximately $425 million. The deal encompasses around 665,000 customer accounts and HSA assets totaling about $2.7 billion. The transfer is expected to conclude in multiple tranches during the first half of 2024, pending regulatory approval. Both companies expressed optimism about enhancing services for customers during and after the transition.
Read more →-HQY
Nov 1, 2021HealthEquity Completes Further Acquisition Expands HSA market share, health plan relationships and adds private label solutions DRAPER, Utah , (GLOBE NEWSWIRE)
HealthEquity Completes Further Acquisition share, health plan relationships and adds private label DRAPER, Utah, (GLOBE NEWSWIRE) - November 1, 2021 - HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest health savings account ("HSA") non-bank custodian, t
Read more →-HQY
Apr 27, 2021Fifth Third Bank HSAs Moving to HealthEquity Draper, Utah - ( GLOBE NEWSWIRE )
Fifth Third Bank HSAs Moving to HealthEquity - (GLOBE NEWSWIRE) - April 27, 2021 - HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the largest independent HSA custodian, today announced it has entered into a definitive agreement with Fifth Third Bank, Natio
Read more →-HQY
Mar 8, 2021HealthEquity Expands Commuter Offering with Luum Acquisition adds options beyond monthly transit passes, strengthening capabilities for the new hybrid workplace DRAPER, Utah , (GLOBE NEWSWIRE)
HealthEquity Expands Commuter Offering adds options beyond monthly transit passes, capabilities for the new hybrid workplace DRAPER, Utah, (GLOBE NEWSWIRE) - March 8, 2021 - HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation's largest independent health savings ac
Read more →-HQY
Jul 7, 2020Copyright 2020 HealthEquity, Inc. All rights reserved. Investor update
Safe harbor 2 This presentation includes information contained in our public filings filed with the Securities and Exchange Commission (SEC ), which public filings are expressly incorporated herein by reference (see http://ir.healthequity.com/ ), and other publicly available info
Read more →-HQY
Aug 30, 2019HealthEquity Completes Acquisition of WageWorks Announces $80-100 Million Investment in Remarkable Service DRAPER, UT, (Globe Newswire)
HealthEquity Completes Acquisition of WageWorks Announces $80-100 Million Investment in Remarkable Service DRAPER, UT, (Globe Newswire) August 30, 2019 HealthEquity, Inc. (NASDAQ: HQY) ( HealthEquity or the Company ) today completed its acquisition of WageWorks, Inc., (NYSE: WA
Read more →-HQY
Jul 30, 2019HealthEquity and WageWorks Announce HSR Clearance DRAPER, Utah and SAN MATEO, California, (Globe Newswire)
HealthEquity and WageWorks Announce HSR Clearance DRAPER, Utah and SAN MATEO, California, (Globe Newswire) July 30, 2019 HealthEquity, Inc. (NASDAQ: HQY) ( HealthEquity ) and WageWorks, Inc., (NYSE: WAGE) ( WageWorks ) today announced that they have received notification of earl
Read more →-HQY
Jul 8, 2019WageWorks, Inc. and Subsidiaries Index to Consolidated Financial Statements Page Reports of Independent Registered Public Accounting Firms 1 Consolidated Balance Sheets 6 Consolidated Statements of Income 7 Consolidated
WageWorks, Inc. and Subsidiaries Index to Consolidated Financial Statements Page Reports of Independent Registered Public Accounting Firms 1 Consolidated Balance Sheets 6 Consolidated Statements of Income 7 Consolidated Statements of Comprehensive Income 8 Consolidated St
Read more →-HQY
Jun 27, 2019HealthEquity to Acquire WageWorks Accelerating Market-Wide Transition to HSAs Delivers sustained growth, significant synergies, rapid deleveraging DRAPER, Utah and SAN MATEO, California, (Globe Newswire)
HealthEquity to Acquire WageWorks Accelerating Market-Wide Transition to HSAs Delivers sustained growth, significant synergies, rapid deleveraging DRAPER, Utah and SAN MATEO, California, (Globe Newswire) June 27, 2019 HealthEquity, Inc. (NASDAQ: HQY) ( HealthEquity ), the natio
Read more →-HQY
Jun 26, 2019UNAUDITED PRO FORMA COMBINED CONDENSED FINANCIAL INFORMATION OF HEALTHEQUITY On
UNAUDITED PRO FORMA COMBINED CONDENSED FINANCIAL INFORMATION OF HEALTHEQUITY On June 26, 2019, HealthEquity, Inc. ( HealthEquity , we , us , our ), our wholly owned subsidiary Pacific Merger Sub Inc. ( Merger Sub ) and WageWorks, Inc. ( WageWorks ) entered into an agreement and
Read more →Competitive Position
How HQY ranks across every disease it competes inCompetitive Position is a premium feature
See how HQY ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial